TAK-771
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for TAK-771, covering 2024-11-25 to 2025-11-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) Participants [Phase 3]